Investor Presentaiton slide image

Investor Presentaiton

sanofi mRNA neuraminidase immunogenicity as strong as Fluzone HD GMTR D29/D01 8 N 1 Neuraminidase inhibition titers (N2) % Seroconversion 100 80 60 40 20 mRNA neuraminidase results - Immune responses comparable to Fluzone HD - NB: Fluzone HD has 2.5 to 3 times higher NA concentrations than SD vaccines and sets the bar for future vaccines¹ - Good tolerability and safety, comparable to Fluzone HD2 0 18-64 years ≥ 65 years 18-64 years ≥ 65 years MRNA NA Fluzone HD 1. Gao Z, Robinson K, Skowronski DM, De Serres G, Withers SG. Vaccine. 2020 Jan 22;38(4):715-718. doi: 10.1016/j.vaccine.2019.11.041 2. Data on file 54 Vaccines Investor Event
View entire presentation